Shandong Loncom Pharmaceutical Co.,ltd.

Overview

Shandong Loncom Pharmaceutical Co.,ltd. is a pharmaceutical company headquartered in Yanbei, China, founded in 2012, with 501-1,000 employees.

Active pharmaceutical ingredients supplied

Substances Shandong Loncom Pharmaceutical Co.,ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Shandong Loncom Pharmaceutical Co.,ltd. holds 23 active (23 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DESLORATADINEActive2026-06-30
• VORTIOXETINE HYDROBROMIDEActive2026-06-30
• ERLOTINIB HYDROCHLORIDEActive2026-06-29
• PAZOPANIB HYDROCHLORIDEActive2026-06-25
• LACOSAMIDEActive2026-05-28
• SORAFENIB TOSILATEActive2026-05-28
• SILODOSINActive2026-05-28
• VARENICLINE TARTRATEActive2026-05-28
• LEVOSIMENDANActive2026-04-29
• PERAMPANEL HYDRATEActive2026-04-29
• TOPIROXOSTATActive2026-04-12
• PARECOXIB SODIUMActive2026-04-03
• DOTINURADActive2026-03-25
• RELUGOLIXActive2026-03-25
• DAPOXETINE HYDROCHLORIDEActive2026-03-23

Showing 15 of 23 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Shandong Loncom Pharmaceutical Co.,ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.